Day: February 14, 2023

Middlefield Banc Corp. Announces 2023 First-Quarter Cash Dividend Payment

Written by Customer Service on February 14, 2023. Posted in Dividend Reports And Estimates.

MIDDLEFIELD, Ohio, Feb. 14, 2023 (GLOBE NEWSWIRE) — Middlefield Banc Corp. (NASDAQ: MBCN) today announced its Board of Directors declared a quarterly cash dividend of $0.20 per common share. The first quarter dividend is payable on March 15, 2023, to shareholders of record on March 3, 2023. The 2023 first-quarter dividend payment represents a 17.6% increase over the 2022 first-quarter cash dividend payment. About Middlefield Banc Corp. Middlefield Banc Corp., headquartered in Middlefield, Ohio, is the bank holding company of The Middlefield Banking Company with total assets of $1.69 billion at December 31, 2022. The Bank operates 22 full-service banking centers and an LPL Financial® brokerage office serving Ada, Beachwood, Bellefontaine, Chardon, Cortland, Dublin, Garrettsville, Kenton, Mantua, Marysville, Middlefield, Newbury,...

Bullion Gold Acquires 36,420 Hectares (364 km²) for Lithium Exploration in Jamésie (James Bay)

Written by Customer Service on February 14, 2023. Posted in Mergers And Acquisitions.

Bodo SM Geology Map Bodo SM Geology MapMONTREAL, Feb. 14, 2023 (GLOBE NEWSWIRE) — Bullion Gold Resources Corp. (TSX-V: BGD) (“Bullion Gold” or “the Company”) announces the acquisition, by way of staking and from a group of prospectors, of 36,320 contiguous hectares forming the Bodo SM property, located approximately 200 km north of the municipality of Chibougamau and about 100 km south of the Eastmain mine. Composed of 682 cells, the Bodo SM project was acquired based on its potential to contain spodumene pegmatites, the presence of a bedrock largely denuded of vegetation and its location which offers very good accessibility due to its proximity to the main road leading to Chibougamau. The geological environment of Bodo SM is similar to that found in the known geological zones containing lithium in the western part of James...

Intelligent Bio Solutions Inc. Reports Fiscal 2023 Second Quarter Financial Results and Operational Highlights

Written by Customer Service on February 14, 2023. Posted in Earnings Releases And Operating Results.

– Second quarter total revenue and government support income increased over 100% year-over-year – – Government support income increased 52% for the quarter ended December 31, 2022 compared to the prior corresponding period, mainly due to qualifying expenditures for completion of Milestone 7 – – Successful completion of Milestone 7, a key phase of its biosensor platform development – – Cash and cash equivalents at quarter-end totaled $2.9 million – NEW YORK, Feb. 14, 2023 (GLOBE NEWSWIRE) — Intelligent Bio Solutions Inc. (“Intelligent Bio Solutions” or the “Company”) (Nasdaq: INBS), a life sciences company developing and delivering intelligent, non-invasive, real-time testing solutions, today announced its financial results for its fiscal second quarter ended December 31, 2022, and...

Outlook Therapeutics® Reports Financial Results for First Quarter Fiscal Year 2023 and Provides Corporate Update

Written by Customer Service on February 14, 2023. Posted in Earnings Releases And Operating Results.

Pre-launch commercial activities underway as Company advances toward U.S. Food and Drug Administration (FDA) Prescription Drug User Fee Act (PDUFA) goal date of August 29, 2023 for ONS-5010 / LYTENAVA™ (bevacizumab-vikg), an investigational ophthalmic formulation for the treatment of wet age-related macular degeneration (wet AMD) Cash runway through the anticipated FDA approval of ONS-5010 in the third calendar quarter of 2023 and into the fourth calendar quarter of 2023ISELIN, N.J., Feb. 14, 2023 (GLOBE NEWSWIRE) — Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company working to develop and launch the first FDA-approved ophthalmic formulation of bevacizumab for use in retinal indications, today announced recent corporate highlights and financial results for its fiscal first quarter ended December 31,...

Reunion Neuroscience Provides Business Update and Reports Fiscal Third Quarter 2023 Financial Results

Written by Customer Service on February 14, 2023. Posted in Earnings Releases And Operating Results.

Company Completed Phase 1 Interim Data Analysis for Lead Asset, RE104, Which Showed Strong Safety and Tolerability with Differentiated Profile; Final Data Anticipated in Mid-2023 Continued to Strengthen Executive Team; Named Dr. Robert Alexander as Chief Medical Officer At December 31, 2022, Reunion Held CAD $32.4 Million in Cash and Cash Equivalents TORONTO, Feb. 14, 2023 (GLOBE NEWSWIRE) — Reunion Neuroscience Inc. (NASDAQ: REUN, TSX: REUN) (“Reunion” or “the Company”), a clinical-stage biopharmaceutical company committed to developing innovative and patented therapeutic solutions for underserved mental health conditions, today provided a business update and reported fiscal results for the third quarter ended December 31, 2022. “This was a transformative quarter for Reunion. We enter 2023 well positioned with both encouraging...

Quipt Home Medical Reports Record First Quarter Fiscal 2023 Financial Results Posting Positive Net Income, Revenue Growth of 38% and Adjusted EBITDA Growth of 50%

Written by Customer Service on February 14, 2023. Posted in Earnings Releases And Operating Results.

Posts Strong Adjusted EBITDA Margin of 22% and Sequential Organic Growth of 2% CINCINNATI, Feb. 14, 2023 (GLOBE NEWSWIRE) — Quipt Home Medical Corp. (the “Company”) (NASDAQ:QIPT; TSXV:QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care, today announced its first quarter fiscal 2023 financial results and operational highlights. These results pertain to the three months ended December 31, 2022 and are reported in U.S. Dollars. Quipt will host its Earnings Conference Call on Tuesday, February 14, 2023 at 10:00 a.m. (ET). The dial-in number is 1 (800) 319-4610 or 1 (604) 638-5340. The live audio webcast can be found on the investor section of the Company’s website through the following link: www.quipthomemedical.com. Financial Highlights:Revenue for fiscal Q1 2023 was $40.8 million compared...

Morphic to Present at SVB Leerink Global Healthcare Conference

Written by Customer Service on February 14, 2023. Posted in Public Companies.

WALTHAM, Mass., Feb. 14, 2023 (GLOBE NEWSWIRE) — Morphic Therapeutic (Nasdaq: MORF), a biotechnology company developing a new generation of oral integrin therapies for the treatment of serious chronic diseases, today announced that its management team will participate in the virtual SVB Leerink Global Healthcare conference including a hosted fireside chat. Presentation Information 8:40 AM ET, Thursday February 16, 2023 Fireside Chat at the SVB Leerink Conference A live webcast of the presentation will be available on the Investor section of Morphic’s website at www.morphictx.com. An archived replay will be available on the company’s website following the conference. About Morphic TherapeuticMorphic Therapeutic is a biopharmaceutical company developing a portfolio of oral integrin therapies for the treatment of serious chronic diseases,...

Athenex Announces a Reverse Stock Split

Written by Customer Service on February 14, 2023. Posted in Public Companies.

BUFFALO, N.Y., Feb. 14, 2023 (GLOBE NEWSWIRE) — Athenex, Inc., (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies for the treatment of cancer and related conditions, today announced that it will effect a 1-for-20 reverse stock split of its issued common stock, effective at 12:01 a.m. Eastern Time on February 15, 2023. Beginning tomorrow, February 15, 2023, the Company’s common stock will trade on a split-adjusted basis. At the Company’s Special Meeting of Stockholders held on November 22, 2022, the Company’s stockholders approved a proposal to authorize a reverse stock split of the Company’s common stock, at a ratio within the range of 1-for-5 to 1-for-20, as determined by the Company’s Board of Directors. The Board of Directors...

South Darlot Gold Project: Endeavour RC Drilling Programme

Written by Customer Service on February 14, 2023. Posted in Public Companies.

Figure 1 Gold mineralisation associated with the narrow quartz vein in 22ENRC017, with some bleeding of grade into the footwall intermediate volcanic.Figure 2 The Endeavour Vein as seen in RC cuttings from drillhole 22ENRC014. Note the significant footwall grade and lack of quartz veining in the chips.Figure 3 Pierce-point long section updated with recent drilling program (recent drilling highlighted in red)Figure 4 Cross section through the Endeavour deposit.Table 1 Drill hole details and significant intersections from the 2023 Endeavour RC drill programme.Figure 5 Locality map of the South Darlot project.VANCOUVER, British Columbia, Feb. 14, 2023 (GLOBE NEWSWIRE) — Central Iron Ore Ltd. (CIO – TSX.V) (“CIO” or “the Company”) is pleased to announce results from the December 2022 RC drilling programme at its...

Polyarylsulfones Market is Predicted to Surpass a Revenue of USD 26.90 Billion by Growing at a CAGR of 19.1% During 2022-2028; Growing Preference for Light Weight Engineering to Elevate Market Growth – SkyQuest

Written by Customer Service on February 14, 2023. Posted in Mergers And Acquisitions.

The research study by SkyQuest on the polyarylsulfones market offers a thorough industry analysis, as well as present market trends and anticipated future developments. For market participants, stakeholders, and investors, this report is a crucial tool that enables them to stay competitive and make well-informed decisions. Important information is covered in the study, including market size worldwide, market share of major players, and market segmentation by geography. The purpose of the research is to give its readers a competitive advantage in the market. Westford USA, Feb. 14, 2023 (GLOBE NEWSWIRE) — North America to dominate the polyarylsulfones market throughout the forecast period. The presence of a well-organized and well-developed thermoplastic industry along with ongoing technological advancements in important end-use...

Day: February 14, 2023

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice